Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells

Isabel Barao, Alan M. Hanash, William Hallett, Lisbeth A. Welniak, Kai Sun, Doug Redelman, Bruce R. Blazar, Robert B Levy, William J. Murphy

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

Naturally occurring CD4+CD25+ T regulatory (Treg) cells have been shown to inhibit adaptive responses by T cells. Natural killer (NK) cells represent an important component of innate immunity in both cancer and infectious disease states. We investigated whether CD4+CD25 + Treg cells could affect NK cell function in vivo by using allogeneic (full H2-disparate) bone marrow (BM) transplantation and the model of hybrid resistance, in which parental marrow grafts are rejected solely by the NK cells of irradiated (BALB/c × C57BL/6) F1 recipients. We demonstrate that the prior removal of host Treg cells, but not CD8+ T cells, significantly enhanced NK cell-mediated BM rejection in both models. The inhibitory role of Treg cells on NK cells was confirmed in vivo with adoptive transfer studies in which transferred CD4+CD25+ cells could abrogate NK cell-mediated hybrid resistance. Anti-TGF-β mAb treatment also increased NK cell-mediated BM graft rejection, suggesting that the NK cell suppression is exerted through TGF-β. Thus, CD4+CD25 + Treg cells can potently inhibit NK cell function in vivo, and their depletion may have therapeutic ramifications for NK cell function in BM transplantation and cancer therapy.

Original languageEnglish
Pages (from-to)5460-5465
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume103
Issue number14
DOIs
StatePublished - Apr 4 2006

Fingerprint

Regulatory T-Lymphocytes
Natural Killer Cells
Bone Marrow Cells
Bone Marrow
Bone Marrow Transplantation
T-Lymphocytes
Bone Neoplasms
Adoptive Transfer
Graft Rejection
Innate Immunity
Communicable Diseases
Therapeutics
Transplants

Keywords

  • Anti-CD25
  • Bone marrow transplantation
  • Foxp3
  • Hybrid resistance

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells. / Barao, Isabel; Hanash, Alan M.; Hallett, William; Welniak, Lisbeth A.; Sun, Kai; Redelman, Doug; Blazar, Bruce R.; Levy, Robert B; Murphy, William J.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, No. 14, 04.04.2006, p. 5460-5465.

Research output: Contribution to journalArticle

Barao, Isabel ; Hanash, Alan M. ; Hallett, William ; Welniak, Lisbeth A. ; Sun, Kai ; Redelman, Doug ; Blazar, Bruce R. ; Levy, Robert B ; Murphy, William J. / Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells. In: Proceedings of the National Academy of Sciences of the United States of America. 2006 ; Vol. 103, No. 14. pp. 5460-5465.
@article{53c7c77c4f304457bf14dea1be1fe36b,
title = "Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells",
abstract = "Naturally occurring CD4+CD25+ T regulatory (Treg) cells have been shown to inhibit adaptive responses by T cells. Natural killer (NK) cells represent an important component of innate immunity in both cancer and infectious disease states. We investigated whether CD4+CD25 + Treg cells could affect NK cell function in vivo by using allogeneic (full H2-disparate) bone marrow (BM) transplantation and the model of hybrid resistance, in which parental marrow grafts are rejected solely by the NK cells of irradiated (BALB/c × C57BL/6) F1 recipients. We demonstrate that the prior removal of host Treg cells, but not CD8+ T cells, significantly enhanced NK cell-mediated BM rejection in both models. The inhibitory role of Treg cells on NK cells was confirmed in vivo with adoptive transfer studies in which transferred CD4+CD25+ cells could abrogate NK cell-mediated hybrid resistance. Anti-TGF-β mAb treatment also increased NK cell-mediated BM graft rejection, suggesting that the NK cell suppression is exerted through TGF-β. Thus, CD4+CD25 + Treg cells can potently inhibit NK cell function in vivo, and their depletion may have therapeutic ramifications for NK cell function in BM transplantation and cancer therapy.",
keywords = "Anti-CD25, Bone marrow transplantation, Foxp3, Hybrid resistance",
author = "Isabel Barao and Hanash, {Alan M.} and William Hallett and Welniak, {Lisbeth A.} and Kai Sun and Doug Redelman and Blazar, {Bruce R.} and Levy, {Robert B} and Murphy, {William J.}",
year = "2006",
month = "4",
day = "4",
doi = "10.1073/pnas.0509249103",
language = "English",
volume = "103",
pages = "5460--5465",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "14",

}

TY - JOUR

T1 - Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells

AU - Barao, Isabel

AU - Hanash, Alan M.

AU - Hallett, William

AU - Welniak, Lisbeth A.

AU - Sun, Kai

AU - Redelman, Doug

AU - Blazar, Bruce R.

AU - Levy, Robert B

AU - Murphy, William J.

PY - 2006/4/4

Y1 - 2006/4/4

N2 - Naturally occurring CD4+CD25+ T regulatory (Treg) cells have been shown to inhibit adaptive responses by T cells. Natural killer (NK) cells represent an important component of innate immunity in both cancer and infectious disease states. We investigated whether CD4+CD25 + Treg cells could affect NK cell function in vivo by using allogeneic (full H2-disparate) bone marrow (BM) transplantation and the model of hybrid resistance, in which parental marrow grafts are rejected solely by the NK cells of irradiated (BALB/c × C57BL/6) F1 recipients. We demonstrate that the prior removal of host Treg cells, but not CD8+ T cells, significantly enhanced NK cell-mediated BM rejection in both models. The inhibitory role of Treg cells on NK cells was confirmed in vivo with adoptive transfer studies in which transferred CD4+CD25+ cells could abrogate NK cell-mediated hybrid resistance. Anti-TGF-β mAb treatment also increased NK cell-mediated BM graft rejection, suggesting that the NK cell suppression is exerted through TGF-β. Thus, CD4+CD25 + Treg cells can potently inhibit NK cell function in vivo, and their depletion may have therapeutic ramifications for NK cell function in BM transplantation and cancer therapy.

AB - Naturally occurring CD4+CD25+ T regulatory (Treg) cells have been shown to inhibit adaptive responses by T cells. Natural killer (NK) cells represent an important component of innate immunity in both cancer and infectious disease states. We investigated whether CD4+CD25 + Treg cells could affect NK cell function in vivo by using allogeneic (full H2-disparate) bone marrow (BM) transplantation and the model of hybrid resistance, in which parental marrow grafts are rejected solely by the NK cells of irradiated (BALB/c × C57BL/6) F1 recipients. We demonstrate that the prior removal of host Treg cells, but not CD8+ T cells, significantly enhanced NK cell-mediated BM rejection in both models. The inhibitory role of Treg cells on NK cells was confirmed in vivo with adoptive transfer studies in which transferred CD4+CD25+ cells could abrogate NK cell-mediated hybrid resistance. Anti-TGF-β mAb treatment also increased NK cell-mediated BM graft rejection, suggesting that the NK cell suppression is exerted through TGF-β. Thus, CD4+CD25 + Treg cells can potently inhibit NK cell function in vivo, and their depletion may have therapeutic ramifications for NK cell function in BM transplantation and cancer therapy.

KW - Anti-CD25

KW - Bone marrow transplantation

KW - Foxp3

KW - Hybrid resistance

UR - http://www.scopus.com/inward/record.url?scp=33645759979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645759979&partnerID=8YFLogxK

U2 - 10.1073/pnas.0509249103

DO - 10.1073/pnas.0509249103

M3 - Article

VL - 103

SP - 5460

EP - 5465

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 14

ER -